Date: 2019-09-27Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision (EU) 2019/1488 of the European Parliament of 26 March 2019 on discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the financial year 2017
Executive Summary:
This document is a decision by the European Parliament to grant discharge to the Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) regarding the implementation of the Centre's budget for the financial year 2017. It outlines observations made in the resolution below and instructs the President to forward the decision and resolution to relevant parties for publication. The decision was made on March 26, 2019.
Key Points / Main Content:
* Discharge:
* Grants discharge to the Director of the EMCDDA for the implementation of the Centre's budget in 2017.
* Observations and Resolution:
* Sets out observations in the resolution below.
* The resolution forms an integral part of the decision.
* Instruction and Publication:
* Instructs the President to forward the decision and resolution to:
* The Director of the EMCDDA
* The Council
* The Commission
* The Court of Auditors
* Arranges for their publication in the Official Journal of the European Union L series.
Impact Analysis:
* Director of the European Monitoring Centre for Drugs and Drug Addiction:
* Impact: Granted discharge in respect of the implementation of the Centre's budget for the financial year 2017.
* Action Required: Receive and acknowledge the decision and resolution.
* Council, Commission, and Court of Auditors:
* Impact: Informed of the discharge decision and the accompanying resolution.
* Action Required: Receive and acknowledge the decision and resolution.
* President of the European Parliament:
* Impact: Responsible for the execution of the decision.
* Action Required: Forward the decision and resolution to the specified parties and arrange for publication in the Official Journal.
Key Entities Referenced
European Parliament: Legislative branch of the European Union.
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA): A decentralised agency of the European Union founded in 1993. Located in Lisbon, it is one of the EU's decentralised agencies.
Council of the European Union: A component of the EU's legislative branch, comprising representatives from each member state's government.
Court of Auditors: The European Court of Auditors (ECA) is one of the institutions of the European Union (EU), established in 1975. It is in charge of auditing EU finances.
Treaty on the Functioning of the European Union: One of the primary treaties of the European Union, outlining its scope and function.
Commission: Refers to the European Commission, an executive branch of the European Union responsible for proposing legislation, enforcing EU laws and directing the Union's administrative operations.
Regulation (EU, Euratom) No 966/2012: A regulation of the European Parliament and the Council on the financial rules applicable to the general budget of the Union.
Regulation (EU, Euratom) 2018/1046: A regulation of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012.
27.9.2019 EN Official Journal of the European Union L 249/239
DECISION (EU) 2019/1488 OF THE EUROPEAN PARLIAMENT
of 26 March 2019
on discharge in respect of the implementation of the budget of the European Monitoring Centre
for Drugs and Drug Addiction (EMCDDA) for the financial year 2017
THE EUROPEAN PARLIAMENT,
— having regard to the final annual accounts of the European Monitoring Centre for Drugs and Drug Addiction for the
financial year 2017,
— having regard to the Court of Auditors' report on the annual accounts of the European Monitoring Centre for Drugs
and Drug Addiction for the financial year 2017, together with the Centre's reply (1),
— having regard to the statement of assurance (2) as to the reliability of the accounts and the legality and regularity of
the underlying transactions provided by the Court of Auditors for the financial year 2017, pursuant to Article 287
of the Treaty on the Functioning of the European Union,
— having regard to the Council's recommendation of 12 February 2019 on discharge to be given to the Centre in
respect of the implementation of the budget for the financial year 2017 (05825/2019 – C8-0071/2019),
— having regard to Article 319 of the Treaty on the Functioning of the European Union,
— having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of
25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council
Regulation (EC, Euratom) No 1605/2002 (3), and in particular Article 208 thereof,
— having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July
2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU)
No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU)
No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation
(EU, Euratom) No 966/2012 (4), and in particular Article 70 thereof,
— having regard to Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December
2006 on the European Monitoring Centre for Drugs and Drug Addiction (5), and in particular Article 15 thereof,
— having regard to Commission Delegated Regulation (EU) No 1271/2013 of 30 September 2013 on the framework
financial regulation for the bodies referred to in Article 208 of Regulation (EU, Euratom) No 966/2012 of the
European Parliament and of the Council (6), and in particular Article 108 thereof,
— having regard to Rule 94 of and Annex IV to its Rules of Procedure,
— having regard to the report of the Committee on Budgetary Control and the opinion of the Committee on Civil
Liberties, Justice and Home Affairs (A8-0139/2019),
1. Grants the Director of the European Monitoring Centre for Drugs and Drug Addiction discharge in respect of the
implementation of the Centre's budget for the financial year 2017;
2. Sets out its observations in the resolution below;
3. Instructs its President to forward this decision, and the resolution forming an integral part of it, to the Director of
the European Monitoring Centre for Drugs and Drug Addiction, the Council, the Commission and the Court of
Auditors, and to arrange for their publication in the Official Journal of the European Union (L series).
The President The Secretary-General
Antonio TAJANI Klaus WELLE
(1) OJ C 434, 30.11.2018, p. 149.
(2) OJ C 434, 30.11.2018, p. 149.
(3) OJ L 298, 26.10.2012, p. 1.
(4) OJ L 193, 30.7.2018, p. 1.
(5) OJ L 376, 27.12.2006, p. 1.
(6) OJ L 328, 7.12.2013, p. 42.